Does China's competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine
With the National Centralized Drug Procurement policy gradually applied nationally in China, concerns about the effectiveness and safety of bid-winning generic drugs are growing again, but relevant studies are lacking. This real-world, before-and-after study was conducted to explore the clinical eff...
Saved in:
Main Authors: | Chao Zhang (Author), Yudan Ding (Author), Zhenzhen Wu (Author), Juan Wang (Author), Xiangping Wu (Author), Weiwei Xie (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL
by: N. P. Kutishenko, et al.
Published: (2016) -
Generic substitution of antidiabetic drugs in the elderly does not affect adherence
by: Francesco Trotta, et al.
Published: (2014) -
Carbamazepine Toxicity with Generic Substitution
by: J Gordon Millichap
Published: (1994) -
Generic Substitutions for Antiepileptic Drugs
by: J Gordon Millichap
Published: (1990) -
Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone®
by: Peter Lipsky, et al.
Published: (2021)